Skip to main content
Home
FULL MENU Close Menu
Home
Home

Steve Stiles

News

Myocarditis by CMR may be rare after COVID-19 in elite athletes

Author:
Steve Stiles
Publish date: January 27, 2021

Some supposed ‘myocarditis’ detected by MRI after COVID-19 in university varsity competitors might be normal heart muscle – normal for athletes,...

  • Read More

News

Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes

Author:
Steve Stiles
Publish date: January 19, 2021

Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...

  • Read More

News

Calcium burden drives CV risk whether coronary disease is obstructive or not

Author:
Steve Stiles
Publish date: December 10, 2020

That future cardiovascular risk tracks closely with plaque burden, but not so much with whether the coronary disease is obstructive, may never...

  • Read More

News

SAMSON pins most muscle pain experienced with statins on the nocebo effect

Author:
Steve Stiles
Publish date: November 16, 2020

Some patients really do get side effects, such as muscle pain, from statins, but the trial suggests that “90% of this symptomatic burden is...

  • Read More

News

Omega-3 caps, vitamin D both fail for atrial fib primary prevention: VITAL-Rhythm

Author:
Steve Stiles
Publish date: November 15, 2020

Neither supplement, here used as drugs, made a difference in risk for incident atrial fibrillation in the 5-year trial. And a secondary...

  • Read More

News

Virtual AHA 2020 may influence template for postpandemic scientific sessions

Author:
Steve Stiles
Publish date: November 11, 2020

The American Heart Association has assembled a virtual meeting that retains many familiar features and formats, and even includes an address from...

  • Read More

News

PCI success vs. meds only in diabetes may depend on LDL-C control

Author:
Steve Stiles
Publish date: November 10, 2020

PCI and LDL-lowering therapy work as a team to cut clinical risk in patients with diabetes and stable coronary disease, but succeed only if LDL-C...

  • Read More

News

The socioeconomic revolving door of 30-day heart failure readmissions

Author:
Steve Stiles
Publish date: October 9, 2020

Racial disparities in 30-day HF readmissions stem partly from variation in economic status of residential neighborhoods, regardless of hospital...

  • Read More

News

‘Cautious’ DOAC underdosing in AFib may push mortality higher

Author:
Steve Stiles
Publish date: September 21, 2020

Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of...

  • Read More

News

Minidose edoxaban may safely cut AFib stroke risk in the frail, very elderly

Author:
Steve Stiles
Publish date: September 3, 2020

Those who took the factor Xa inhibitor edoxaban (Savaysa) at the off-label dosage of 15 mg once daily showed a two-thirds drop in risk for stroke...

  • Read More

News

EXPLORER trial hints at potential new drug option in obstructive hypertrophic cardiomyopathy

Author:
Steve Stiles
Publish date: August 30, 2020

Mavacamten, which seemed to improve function and alleviate symptoms in the short trial, is the first potential drug for the disorder that...

  • Read More

News

Vast underdiagnosis of monogenic CV disease seen in cath referrals

Author:
Steve Stiles
Publish date: August 12, 2020

Most such patients with a heart disease–linked gene variant and who showed clinical signs of the disease did not receive a diagnosis, in a study...

  • Read More

News

All NSAIDs raise post-MI risk but some are safer than others: Next chapter

Author:
Steve Stiles
Publish date: August 5, 2020

A new cohort analysis extends NSAID cautions in high-CV-risk patients to a Korean population. Some question whether the steep climbs in risk seen...

  • Read More

News

Heart damage even after COVID-19 ‘recovery’ evokes specter of later heart failure

Author:
Steve Stiles
Publish date: July 31, 2020

Recovery from acute COVID-19 isn’t necessarily the end of it, clearly. Two reports aim to clarify how SARS-CoV-2 can directly invade the heart and...

  • Read More

News

SCD-HeFT 10-year results: Primary-prevention ICD insights in nonischemic heart failure

Author:
Steve Stiles
Publish date: July 31, 2020

The trial’s most recent results add to ongoing controversy – fueled by DANISH and other studies – about whether primary-prevention ICDs prolong...

  • Read More

Pages

  • 1
  • 2
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close